Papers
6
Total Citations
395
H-Index
3
About
Marcus Cumberbatch is a leading urological surgeon and researcher whose work is reshaping the surgical management of bladder and prostate cancers. His primary research areas include robotic-assisted surgery for urological malignancies, comparative effectiveness of surgical techniques, and focal therapy for prostate cancer. Cumberbatch’s most impactful contribution is his landmark 2022 study on the IROC trial, which compared robot-assisted radical cystectomy with intracorporeal urinary diversion to open surgery for bladder cancer. With 320 citations, this pivotal work provided critical evidence on recovery and morbidity outcomes, guiding clinical practice toward minimally invasive approaches. He also authored a comprehensive systematic review on focal ablative therapy for localized prostate cancer, highlighting limitations in current evidence and offering recommendations for clinical practice and future research. Additionally, his work on robot-assisted partial nephrectomy for imperative versus elective indications, drawing from a multinational database of over 3,800 patients, has informed surgical decision-making in nephron-sparing surgery. Cumberbatch’s research is characterized by rigorous methodology and a focus on patient-centered outcomes, making him a key figure in advancing evidence-based urological surgery.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3
- 4
- 5
- 6